Loading…
Based on limited metadata, Corona-cure.com, an online drug seller, received an FDA Warning Letter on March 26, 2020, indicating regulatory concerns with their products or operations. While the specific violations are not detailed in the available metadata, the warning falls under FDA's drug product oversight authority. Without access to the full letter text, the exact nature of the compliance issues cannot be determined, but they likely relate to unapproved drug claims, manufacturing standards, or misleading marketing practices common to online pharmaceutical vendors.